Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta‐analysis

@article{Katz2008LamivudinePR,
  title={Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta‐analysis},
  author={L. Katz and A. Fraser and A. Gafter‐Gvili and L. Leibovici and R. Tur-Kaspa},
  journal={Journal of Viral Hepatitis},
  year={2008},
  volume={15}
}
  • L. Katz, A. Fraser, +2 authors R. Tur-Kaspa
  • Published 2008
  • Medicine
  • Journal of Viral Hepatitis
  • Summary.  To assess the effects of prophylactic lamivudine on reactivation and mortality following immunosuppressive therapy in hepatitis B surface antigen (HBsAg)‐positive patients, we performed a meta‐analysis. Systematic review and meta‐analysis of randomized and nonrandomized prospective controlled trials and retrospective comparative case series were identified through The Cochrane Hepato‐Biliary Group Controlled Trials Register, The Cochrane Central Register of Controlled Trials, MEDLINE… CONTINUE READING
    133 Citations
    Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis
    • 10
    Chemoprevention of Patients with Hepatitis B Receiving Chemotherapy or Bone Marrow Transplant
    • 1
    • Highly Influenced
    Entecavir is an optional agent to prevent hepatitis B virus (HBV) reactivation: a review of 16 patients.
    • 32
    Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy
    • 12

    References

    SHOWING 1-10 OF 83 REFERENCES
    Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.
    • W. Yeo, P. Chan, +9 authors P. Johnson
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2004
    • 239
    Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients.
    • L. Hsiao, T. Chiou, +8 authors P. Chen
    • Medicine
    • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
    • 2006
    • 51